Skip to content

Author

Yucai Wang

We have 2 of 59 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Patterns of care, outcomes, and prognostics for transformed follicular lymphoma in the rituximab era.

Histologic transformation (HT) is the leading of death in follicular lymphoma (FL), yet outcomes remain poorly defined due to small cohorts and heterogenous definitions. To characterize outcomes and treatment patterns in the rituximab era we analyzed 344 patients with an initial biopsy-confirmed FL diagnosis between 20...

J. Day, M. Larson, C. Casulo et al. · 0 citations
Open access Aug 2026

Malignant B-cell States Orchestrate Spatially Organized Immune Ecosystems in B-cell Lymphomas

Findings establish malignant differentiation state as a causal determinant of immune architecture across GC-derived lymphomas and identify lineage-directed immune reprogramming as a potential therapeutic strategy.

P. Mondello, A. Sadekova, ksenia fede et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.